Neothetics' abdominal bulging drug fails in trials, stock plunges

(Reuters) - Neothetics Inc said its experimental treatment for reducing abdominal bulging failed in two late-stage studies, sending its shares down 64 percent in extended trading.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro